Dr Kardeby is a cell signalling scientist with years of experience in drug target identification. Her research is in the field of Thrombosis in Inflammation with a focus on the effect of platelet and endothelial cell activation on vascular remodelling and neurodegeneration. In her work she uses novel pharmacological tools for understanding signalling mechanisms of cardiovascular disease.

My research group currently consists of Dr Marcela Usmari Moraes, Miss Nusratul Firdaus, and one more PhD student joining us from October.

Dr Kardeby is a Marie Curie Alumni, she held a Marie Skłodowska-Curie Actions Individual Fellowship funded by Horizon 2020 between 2020 and 2022 (#893262).

Dr Kardeby is a registered clinical Biomedical Scientist with the Swedish National Board of Health and Welfare. She has experience from working in clinical chemistry, histolgy and pathology, fertility laboratory, and a general practician surgery.

The Connection Between Increased Thrombotic Risk and Parkinson’s – Currently recruiting

The full title of this project is Investigating a novel mechanism underlying increased risk of vascular events in Parkinson’s disease:
Dissecting pathological synergy between protein aggregates and glycosaminoglycans. It is funded by the British Heart Foundation and in collaboration with the University Hospitals Birmingham NHS Foundation Trust, this study aims to investigate whether individuals living with Parkinson’s have more easily activated platelets in their blood and to understand how alpha-synuclein and inflammation contributes to thrombosis. 

PhD Project – Peripheral blood markers in South Asians with and without established coronary artery disease

This project is a joint collaboration between the Sandwell and West Birmingham Hospitals NHS Trust and Aston University, funded 50-50 by the Listers Group and Aston University. In this project we aim to understand why individuals with South Asian ancestry are at increased risk of cardiovascular disease.

PhD Project – Haemostatic dysregulation as a marker of blood brain barrier malfunction – Starting soon 

This project is funded by the Dunhill Medical Trust, it is a part of the Aston Brain Health Cohort Study (ABaHCoS) that sits at the heart of the Aston Research Centre for Health in Ageing. This study will contribute towards finding new tools to identify individuals at risk of dementia earlier. The study is anticipated to start in October 2024 – more information coming soon.